Treatment | Author | Study Design | LCQ change |
---|---|---|---|
BCST | Ryan et al., 200938 | Prospective case series | 7.1 |
 | Ryan et al., 201039 | Prospective case series | 3.4 |
 | Patel et al., 201166 | Prospective case series | 2.7 |
 | Vertigan et al., 201667 | Parallel RCT | 3.3 |
 | Chamberlain et al., 201635 | Parallel RCT | 3.4 |
 | Wright et al., 202168 | Prospective case series | 4.4 |
 | Slovarp et al., 202136 | Prospective case series | 4.6 |
 | Kapela et al., 202069 | Prospective RCT | 3.2 |
Neuromodulators | Ryan et al. 201259 | Parallel RCT | 2.5 |
 | Bowen et al. 201858 | Prospective cohort | 2.5 |
BCST + Pregabalin | Vertigan et al. 201667 | Parallel RCT | 6.6 |
Opiate | Morice et al. 200760 | Crossover RCT | 3.2 |
P2X3 antagonist | Smith et al. 202061 | Crossover RCT | 3.6 |
 | Morice et al. 202165 | Crossover RCT | 2.3 |